Kevin Pfleger

Professor Kevin Pfleger has over 20 years of experience in biomedical research, having been trained at Cambridge and Edinburgh Universities. He has held three nationally-competitive research fellowships and won multiple awards for his research in both endocrinology and pharmacology as well as leadership, innovation and community engagement. Prof Pfleger is an internationally-recognised medical researcher whose research into the cells of the body at a molecular level is regarded as world-leading by his peers, and has the potential to deal with kidney disease which affects 80,000 patients in WA alone. His ASX-listed company Dimerix, spun out of the lab at the Harry Perkins Institute of Medical Research and University of WA, is now running phase 2 clinical trials on this discovery. In May 2019, Prof Pfleger was appointed by the University of WA as director of the newly established WA Life Sciences Innovation Hub where he will bring together researchers, government and industry partners across the State, connecting outwards nationally and internationally, to facilitate biomedical innovation, and generate new business & investment opportunities for Western Australia in biotechnology, medicine and health.
Bio last updated 09 May 2019

Article Timeline

Network Graph

Displaying all related organisations and their related contacts. Hover over a node to display a link to the BNiQ page for that person or organisation.

Access to our data for Kevin Pfleger is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Kevin Pfleger is linked to 3 organisations which are included in 2 lists - Charitable Organisations and Tertiary Education & Training Providers.

To see the data you will need to .


Director, WA Life Sciences Innovation Hub
Head, Molecular Endocrinology & Pharmacology
Chief Scientific Adviser
Year started and most recent title

BNiQ Disclaimer